Abstract
Get full access to this article
View all access options for this article.
References
1.WHO . BCG Vaccine 2023, https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/vaccines-quality/bcg (accessed 31 October 2023) .
2.
Lobo
N
Brooks
NA
Zlotta
AR
, et al. 100 Years of Bacillus Calmette–Guérin immunotherapy: from cattle to COVID-19 . Nat Rev Urol 2021 ; 18 : 611 –622 .
3.
Geddes
L
. Routine vaccines – tuberculosis | Gavi, the vaccine alliance 2023, https://www.gavi.org/vaccineswork/routine-vaccines-tuberculosis (accessed 31 October 2023) .
4.
Martinez
L
Cords
O
Liu
Q
, et al. Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis . Lancet Glob Health 2022 ; 10 : e1307 –e1316 .
5.WHO . The End TB Strategy 2023, https://www.who.int/teams/global-tuberculosis-programme/the-end-tb-strategy (accessed 31 October 2023) .
6.
Van Der Meeren
O
Hatherill
M
Nduba
V
, et al. Phase 2b controlled trial of M72/AS01E vaccine to prevent Tuberculosis . N Engl J Med 2018 ; 379 : 1621 –1634 .